» Articles » PMID: 22253051

Pro-apoptotic Gene Knockdown Mediated by Nanocomplexed SiRNA Reduces Radiation Damage in Primary Salivary Gland Cultures

Overview
Journal J Cell Biochem
Date 2012 Jan 19
PMID 22253051
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

A critical issue in the management of head and neck tumors is radioprotection of the salivary glands. We have investigated whether siRNA-mediated gene knock down of pro-apoptotic mediators can reduce radiation-induced cellular apoptosis in salivary gland cells in vitro. We used novel, pH-responsive nanoparticles to deliver functionally active siRNAs into cultures of salivary gland cells. The nanoparticle molecules are comprised of cationic micelles that electrostatically interact with the siRNA, protecting it from nuclease attack, and also include pH-responsive endosomolytic constituents that promote release of the siRNA into the target cell cytoplasm. Transfection controls with Cy3-tagged siRNA/nanoparticle complexes showed efficiently internalized siRNAs in more than 70% of the submandibular gland cells. We found that introduction of siRNAs specifically targeting the Pkcδ or Bax genes significantly blocked the induction of these pro-apoptotic proteins that normally occurs after radiation in cultured salivary gland cells. Furthermore, the level of cell death from subsequent radiation, as measured by caspase-3, TUNEL, and mitochondrial disruption assays, was significantly decreased. Thus, we have successfully demonstrated that the siRNA/nanoparticle-mediated knock down of pro-apoptotic genes can prevent radiation-induced damage in submandibular gland primary cell cultures.

Citing Articles

Potential of oligonucleotide- and protein/peptide-based therapeutics in the management of toxicant/stressor-induced diseases.

Sadeghian I, Akbarpour M, Chafjiri F, Chafjiri P, Heidari R, Morowvat M Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(3):1275-1310.

PMID: 37688622 DOI: 10.1007/s00210-023-02683-3.


Gene Therapeutic Delivery to the Salivary Glands.

Upadhyay A, Cao U, Hariharan A, Almansoori A, Tran S Adv Exp Med Biol. 2023; 1436:55-68.

PMID: 36826746 DOI: 10.1007/5584_2023_766.


Pharmacological Activation of cGAS for Cancer Immunotherapy.

Garland K, Rosch J, Carson C, Wang-Bishop L, Hanna A, Sevimli S Front Immunol. 2021; 12:753472.

PMID: 34899704 PMC: 8662543. DOI: 10.3389/fimmu.2021.753472.


Rigor and reproducibility in polymer nanoparticle synthesis and characterization.

Sims Jr K, Maceren J, Strand A, He B, Overby C, Benoit D RSC Adv. 2021; 10(5):2513-2518.

PMID: 34631039 PMC: 8496373. DOI: 10.1039/C9RA10091A.


Functional proteomic analysis reveals roles for PKCδ in regulation of cell survival and cell death: Implications for cancer pathogenesis and therapy.

Speidel J, Affandi T, Jones D, Ferrara S, Reyland M Adv Biol Regul. 2020; 78:100757.

PMID: 33045516 PMC: 8294469. DOI: 10.1016/j.jbior.2020.100757.


References
1.
Kishi T, Takao T, Fujita K, Taniguchi H . Clonal proliferation of multipotent stem/progenitor cells in the neonatal and adult salivary glands. Biochem Biophys Res Commun. 2005; 340(2):544-52. DOI: 10.1016/j.bbrc.2005.12.031. View

2.
Stephens L, Schultheiss T, Small S, Ang K, Peters L . Response of parotid gland organ culture to radiation. Radiat Res. 1989; 120(1):140-53. View

3.
Convertine A, Benoit D, Duvall C, Hoffman A, Stayton P . Development of a novel endosomolytic diblock copolymer for siRNA delivery. J Control Release. 2008; 133(3):221-9. PMC: 3110267. DOI: 10.1016/j.jconrel.2008.10.004. View

4.
Jensen S, Pedersen A, Vissink A, Andersen E, Brown C, Davies A . A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer. 2010; 18(8):1061-79. DOI: 10.1007/s00520-010-0837-6. View

5.
Hisatomi Y, Okumura K, Nakamura K, Matsumoto S, Satoh A, Nagano K . Flow cytometric isolation of endodermal progenitors from mouse salivary gland differentiate into hepatic and pancreatic lineages. Hepatology. 2004; 39(3):667-75. DOI: 10.1002/hep.20063. View